EGFR and lung adenocarcinoma: The risk of lung adenocarcinoma in patients with EGFR mutation-positive pulmonary nodules carrying the DD genotype (OR = 0.312, 95% CI, 0.101–0.968, p = 0.044) is lower than that in patients carrying genotype II.